ConductScience.org, home

Paper36943247

Clozapine Optimization: A Delphi Consensus Guideline From the Treatment Response and Resistance in Psychosis Working Group.

Wagner E and 11 others. Schizophr Bull, 2023. Cited by 34 papers, by iCite.

Cite this record

ConductScience Library. Clozapine Optimization: A Delphi Consensus Guideline From the Treatment Response and Resistance in Psychosis Working Group. Papers, record 36943247. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36943247

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Clozapine Optimization: A Delphi Consensus Guideline From the Treatment Response and Resistance in Psychosis Working Group.
PubMed
Journal
Schizophr Bull
PubMed
Year
2023
PubMed
Publication types
Journal Article, Practice Guideline, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
34
iCite
Relative citation ratio, by iCite
6
iCite
Revised in PubMed
2026-05-18
PubMed

Authors12

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Wagner EElias
2Siskind DDan
3Falkai PPeter
4Howes OOliver
5Correll CChristoph
6Lee JJimmyhttps://orcid.org/0000-0002-7724-7445
7Honer WGWilliam G
8Kane JMJohn M
9Fernandez-Egea EEmiliohttps://orcid.org/0000-0003-4128-8955
10Barnes TREThomas R E
11Hasan AAlkomiet
12TRRIP Working GroupGroup

Source PubMed

Download CSV of authors

Topics5

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
ClozapineMajor topic
Psychotic DisordersMajor topic
Humans
Consensus
Delphi Technique

References55

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
122834451
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, part 1: update 2012 on the acute treatment of schizophrenia and the management of treatment resistance.
World J Biol Psychiatry2012https://conductscience.org/library/papers/22834451PubMed
234588212Metformin in the management of antipsychotic-induced weight gain in adults with psychosis: development of the first evidence-based guideline using GRADE methodology.Evid Based Ment Health2022https://conductscience.org/library/papers/34588212PubMed
328747065Use of granulocyte-colony stimulating factor to prevent recurrent clozapine-induced neutropenia on drug rechallenge: A systematic review of the literature and clinical recommendations.Aust N Z J Psychiatry2017https://conductscience.org/library/papers/28747065PubMed
435086595Treatment strategies for clozapine-induced nocturnal enuresis and urinary incontinence: a systematic review.CNS Spectr2022https://conductscience.org/library/papers/35086595PubMed
527716110Metformin in prevention and treatment of antipsychotic induced weight gain: a systematic review and meta-analysis.BMC Psychiatry2016https://conductscience.org/library/papers/27716110PubMed
635164895Clozapine-induced gastrointestinal hypomotility: presenting features and outcomes, UK pharmacovigilance reports, 1992-2017.Br J Psychiatry2022https://conductscience.org/library/papers/35164895PubMed
735210430Systematic literature review of schizophrenia clinical practice guidelines on acute and maintenance management with antipsychotics.Schizophrenia (Heidelb)2022https://conductscience.org/library/papers/35210430PubMed
831365048
Association With Hospitalization and All-Cause Discontinuation Among Patients With Schizophrenia on Clozapine vs Other Oral Second-Generation Antipsychotics: A Systematic Review and Meta-analysis of Cohort Studies.
JAMA Psychiatry2019https://conductscience.org/library/papers/31365048PubMed
929455687Distinct risk factors for obsessive and compulsive symptoms in chronic schizophrenia.Psychol Med2018https://conductscience.org/library/papers/29455687PubMed
1031205196Clozapine Rechallenge Following Neuroleptic Malignant Syndrome: A Systematic Review.J Clin Psychopharmacol2019https://conductscience.org/library/papers/31205196PubMed
1122831769Immunomodulatory effects of clozapine and their clinical implications: what have we learned so far?Schizophr Res2012https://conductscience.org/library/papers/22831769PubMed
1233543755There Is Life After the UK Clozapine Central Non-Rechallenge Database.Schizophr Bull2021https://conductscience.org/library/papers/33543755PubMed
1334911124An International Adult Guideline for Making Clozapine Titration Safer by Using Six Ancestry-Based Personalized Dosing Titrations, CRP, and Clozapine Levels.Pharmacopsychiatry2022https://conductscience.org/library/papers/34911124PubMed
1430758782Treatment Strategies for Clozapine-Induced Sialorrhea: A Systematic Review and Meta-analysis.CNS Drugs2019https://conductscience.org/library/papers/30758782PubMed
1531766049Heterogeneity and efficacy of antipsychotic treatment for schizophrenia with or without treatment resistance: a meta-analysis.Neuropsychopharmacology2020https://conductscience.org/library/papers/31766049PubMed
1634552059Efficacy and safety of clozapine in psychotic disorders-a systematic quantitative meta-review.Transl Psychiatry2021https://conductscience.org/library/papers/34552059PubMed
1734374073Clozapine levels as a predictor for therapeutic response: A systematic review and meta-analysis.Acta Psychiatr Scand2021https://conductscience.org/library/papers/34374073PubMed
1831922665Pneumonia may be more frequent and have more fatal outcomes with clozapine than with other second-generation antipsychotics.World Psychiatry2020https://conductscience.org/library/papers/31922665PubMed
1934715441Clozapine-induced myocarditis and patient outcomes after drug rechallenge following myocarditis: A systematic case review.Psychiatry Res2021https://conductscience.org/library/papers/34715441PubMed
2022113154When can patients with potentially life-threatening adverse effects be rechallenged with clozapine? A systematic review of the published literature.Schizophr Res2012https://conductscience.org/library/papers/22113154PubMed

See all 55 referencesDownload CSV of references

Cited by19

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 34 citations.

PMIDTitleJournalYearIn PapersSource
42951688Clozapine Augmentation Strategies and Clinical Predictors of Prolonged Tertiary Hospitalization in Clozapine-Resistant Schizophrenia: a Retrospective Cohort Study.Schizophr Bull2026https://conductscience.org/library/papers/42951688PubMed
42882089Clinical Outcomes and Treatment Characteristics of Seizure Threshold-Titrated Electroconvulsive Therapy in Schizophrenia: A 3.5-Year Retrospective Naturalistic Course-Level Study.J Clin Med2026https://conductscience.org/library/papers/42882089PubMed
42668991Physical Therapies and Neuromodulation for Treatment-Resistant Schizophrenia: A Review of Potential Mechanisms, Efficacy, and Safety.Neuropsychiatr Dis Treat2026https://conductscience.org/library/papers/42668991PubMed
42136416Real-world comprehensive care of people living with schizophrenia: recommendations across different settings and clinical stages.World Psychiatry2026https://conductscience.org/library/papers/42136416PubMed
41613742A Call to Action for Starting Clozapine: Increasing Clozapine Use and Safety in a Post-REMS Era.Focus (Am Psychiatr Publ)2025https://conductscience.org/library/papers/41613742PubMed
40843609Clozapine Dose Reduction in Remitted Patients With Treatment-Resistant Schizophrenia: A Case Series.Schizophr Bull2026https://conductscience.org/library/papers/40843609PubMed
40445982Violence victimization and perpetration within the caregiver-patient relationship in schizophrenia: A cross-sectional study in Tunisia.PLoS One2025https://conductscience.org/library/papers/40445982PubMed
40371869Effectiveness of clozapine augmentation with specific doses of other antipsychotics in schizophrenia: a meta-analysis from two nationwide cohorts.World Psychiatry2025https://conductscience.org/library/papers/40371869PubMed
40198784
Letter to the FDA Proposing Major Changes in the US Clozapine Package Insert Supported by Clozapine Experts Worldwide. Part II: A Review of Fatal Outcomes in US Pharmacovigilance Data and Proposed Changes.
J Clin Psychopharmacol2025https://conductscience.org/library/papers/40198784PubMed
40121574Clozapine-Related Tachycardia: An Analysis of Incidence.CNS Drugs2025https://conductscience.org/library/papers/40121574PubMed
40070369A Review of Clinical Advances and Challenges in Clozapine-Induced Myocarditis.Neuropsychiatr Dis Treat2025https://conductscience.org/library/papers/40070369PubMed
39598541Manipulation of Lipid Nanocapsules as an Efficient Intranasal Platform for Brain Deposition of Clozapine as an Antipsychotic Drug.Pharmaceutics2024https://conductscience.org/library/papers/39598541PubMed
39359152Understanding the medication regimens associated with anticholinergic burden in older people's mental health services in the UK.BJPsych Open2024https://conductscience.org/library/papers/39359152PubMed
39199294What Remains to Be Discovered in Schizophrenia Therapeutics: Contributions by Advancing the Molecular Mechanisms of Drugs for Psychosis and Schizophrenia.Biomolecules2024https://conductscience.org/library/papers/39199294PubMed
38951464When, Why and How to Re-challenge Clozapine in Schizophrenia Following Myocarditis.CNS Drugs2024https://conductscience.org/library/papers/38951464PubMed
38713070Clozapine Efficacy and Adverse Drug Reactions Among a Nationwide Study of 1021 Australians Prescribed Clozapine: The ClozaGene Study.Schizophr Bull2025https://conductscience.org/library/papers/38713070PubMed
38236524Evaluating Monitoring Guidelines of Clozapine-Induced Adverse Effects: a Systematic Review.CNS Drugs2024https://conductscience.org/library/papers/38236524PubMed
38165458Vaccination and clozapine use: a systematic review and an analysis of the VAERS database.Eur Arch Psychiatry Clin Neurosci2025https://conductscience.org/library/papers/38165458PubMed
37489558CONSENSUS BY THE COLLECTIVE OF PSYCHIATRISTS FOR THE CLOZAPINE UPDATE.Actas Esp Psiquiatr2023https://conductscience.org/library/papers/37489558PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36943247

GET https://conductscience.org/api/papers/v1/36943247/references?page=2